期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

技术变革对新药研发组织模式演化的影响 被引量：2

Impact of technological changes on the evolution of modes of organizing pharmaceutical R&D
原文传递
导出
摘要 制药产业是典型的知识、技术密集型产业,技术变革对新药的研发组织模式产生重大影响。本文借助组织演化理论建立分析框架,追溯了研发组织模式在技术变革影响下的演化历程,分析了演化的机制和趋势。研究提出:技术变革通过改变新药研发的技术范式与流程,引入新的管理技术与手段来实现组织模式的演化;在其驱动下,新药研发组织模式的演化已经并继续呈现网络化的趋势。 As typical knowledge- and technology-intensive, pharmaceutical industry is much impacted by technological changes in terms of modes of pharmaceutical R＆D. An analysis framework was established in this pa- per by employing organization evolution theory to investigate the evolution and trend driven by technological chan- ges. It is proposed that the modes of organizing pharmaceutical R＆D evolved by changing drug R＆D technological paradigms and processes will indirectly introduce new management techniques and measures. The modes are be- coming networked and will continue to evolve.
作者 张立国 王松俊 毛军文
机构地区 军事医学科学院科技部 军事医学科学院卫生勤务与医学情报研究所
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第19期2232-2236,共5页 Chinese Journal of New Drugs
关键词 技术变革 新药研发组织模式 演化 technological change modes of organizing pharmaceutical R＆D evolution
分类号 R95 [医药卫生—药学]
  • 相关文献

参考文献14

  • 1国务院关于印发“十二五”国家战略性新兴产业发展规划的通知[EB/OL].http://www.gov.cn/zwgk/2012-07/20/content一2187770.htm.
  • 2马家喜,仲伟俊,梅姝娥.企业技术创新组织模式选择范式研究[J].科学学与科学技术管理,2008,29(5):52-59. 被引量：13
  • 3王军.产业组织演化[M].北京:经济科学出版社,2008:44-47.
  • 4[荷]赛特斯.杜马,海因.斯赖德.组织经济学-经济学分析方法在组织管理上的应用[M].北京:华夏出版社,2006:223-230.
  • 5HARA T. Innovation in the pharmaceutical industry: the progre- cess of drug discovery and development[ M ]. Northampton, Mas- sachusetts, USA : Edward Elgar Publishing Inc, 2003 : 8 - 37.
  • 6LEE J. Innovation and strategic divergence: an empirical study of the U.S. pharmaceutical industry from 1920 to 1960[J]. Man- age Sci, 2003, 49(2) : 143 - 159.
  • 7ARGYRES NS, LIEBESKIND JP. Governance inseparability and the evolution of US biotechnology industry[ J]. J Econ Behav Or- gan, 2002, 47(2) : 197 -219.
  • 8AUGEN J. The evolving role of information technology in the drug discovery process [ J ]. Drug Discov Today, 2002, 7 ( 5 ) : 315 - 323.
  • 9HOPKINS MM, MARTIN PA, PAUL N, et al. The myth of the biotech revolution: an assessment of technological, clinical and organisational change [ J ]. Res Policy, 2007, 36 (4): 566- 589.
  • 10ROIJAKKERS N, HAGEDOORN J. Inter-firm R&D partnering in pharmaceutical bioteehnology since 1975: trends, patterns, and networks[J]. Res Policy, 2006, 35(3): 431 -446.

二级参考文献37

  • 1许春,刘奕.企业间研发合作组织模式选择的知识因素[J].研究与发展管理,2005,17(5):58-63. 被引量：26
  • 2首藤信彦.超越国际技术联合.世界经济评论,1993,(8):25-25.
  • 3Dae-Hyun,C.,Pyung-Ⅱ,Y.Influential factors in the choice of technology acquisition mode:An empirical analysis of small and medium size firms in the Korean telecommunication industry[J].Technovation,2000,20(12):691-704
  • 4Hongxin Zh,Xuesong T,Wong PK,Jishan Zh.Types of technology sourcing and innovation capability:an exploratory study of Singapore manufacturing firms[J].Journal of High Technology Management Research,2005,16(2):209-224
  • 5Negassi,S.R&D cooperation and innovation a micro-econometric study on French firms[J].Research Policy,2004,33(3):365-384
  • 6Hagedoorn,J.,Link,AN,,Vonortas,NS.Research partnerships[J].Research Policy,2000,29(4-5):567-586
  • 7Nagarajan,A.,Mitchell,W.Evolutionary diffusion:internal and external methods used to acquire encompassing,complementary,and incremental technological changes in the lithotripsy industry[J].Strategic Management Journal,1998,19(11):1063-1067
  • 8Charlene,L,Nixon,N.,Carolyn,Y.W.Technology sourcing and output of established firms in a regime of encompassing technological change[J].Strategic Management Journal,2003,24(7):651-666
  • 9Cadiano,R.,Chiesa,V.,Manzini,R.Differences and similarities in managing technological collaborations in research,development and manufacturing:a case study[J].Journal of Engineering and Technology Management,2000,17(2):193-224
  • 10Hagedoornd,J.Understanding the rationale of strategic technology partnering:inter-organizational modes of cooperation and sectoral differences[J].Strategic Management Journal,1993,14(5):371-385

共引文献14

同被引文献40

  • 1贾怀勤.管理研究方法[M].北京:机械工业出版社,2007:95-96.
  • 2SUNDGREN M, STYHRE A. Creativity and the fallacy of mis- placed concreteness in new drug development: A Whiteheadian perspective[J]. Ear J lnnov Manag, 2007, 10(2) :215 -235.
  • 3STYHRE A. Science-based innovation as systematic risk-taking: The case of new drug development [ J ]. Ear J lnnov Manag, 2006,9(3) :300 -311.
  • 4CRAWFORD MC. New Products Management[M]. McGraw Hill Higher Education ,2014:95 - 98.
  • 5ORCIK A, ANISIC Z, GECEVSKA V, et al. Implementation of PLM strategy in the process of the new product development in chemical industry [ J ]. Proceeding Od Motsp, 2012, ( 2 ) : 90 - 111.
  • 6SLATER SF, HULT GTM, OLSON EM. On the importance of matching strategic behavior and target market selection to business strategy in high-tech markets [ J ]. J Acad Marketing Sci, 2007, 35(1):5-17.
  • 7TAGHIPOURIAN MJ. Social marketing, green marketing: the extension of marketing concept [ J ]. Eur J Econ Finance Admin Sci, 2011, (41) :20 - 33.
  • 8德鲁克.创新与企业家精神(珍藏版)[M].北京:机械工业出版社,2009:58-61.
  • 9Hengstler JG,Bolt HM.Failure in drug development:the role of inhibition and induction of cytochrome P450enzymes[J].Arch Toxicol,2008,82(10):665.
  • 10Kola I.The state of innovation in drug development[J].Clin Pharmacol Ther,2008,83(2):227.

引证文献2

二级引证文献3

中国新药杂志
2013年 第19期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部